1Second Chinese Cardiac Study(CCS-2)Collaborative Group.Rationale,design and organization of the Second Chinese Cardiac Study(CCS-2):a randomized trial of clopidogrel plus aspirin,and of metoprolol,among patients with suspected acute myocardial infarction.
2Yusuf S,Peto R,Lewis J,et al.Beta blockade during and after myocardial infarction:an overview of the randomized trials.Prog Cardiovasc Dis,1985,27:335-371.
3First International Study of Infarct Survival Collaborative Group.Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction:ISIS-1.Lancet,1986,2:57-66.
4Hjalmarson A,Goldstein S,Fagerberg B,et al.Effects of controlled-release metoprolol on total mortality,hospitalizations,and well-being in patients with heart failure:the Metoprolol GR/XL.Randomized Intervention Trial in congestive heart failure(MERIT-HF).
6Yusuf S,Wittes J,Friedman L.Overview of results of randomized clinical trials in heart disease.II.Unstable angina,heart failure,primary prevention with aspirin,and risk factor modification.JAMA,1988,260:2259-2263.
7Khan MG.Management of angina.In:Khan MG,ed.Cardiac drug therapy.6th ed.Saunders:Elsevier Science,2003.197.
8Barron HV,Rundle AC,Gore JM,et al.Intracranial hemorrhage rates and effect of immediate beta-blocker use in patients with acute myocardial infarction treated with tissue plasminogen activator.Participants in the National Registry of Myocardial Infarction-
9Harjai KJ,Stone GW,Boura J,et al.Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction.Am J Cardiol,2003,91:655-660.
10Abrams J,Allen J,Allin D,et al.Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias:a multicenter double-blind clinical trial.Am Heart J,1985,110:913-922.
二级参考文献6
1[1]Second Chinese Cardiac Study (CCS-2) Collaborative Group. Rational, design and organization of the Second Chinese Cardiac Study (CCS-2): A randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. J Cardiovasc Risk,2000,7:435-441.
2[2]ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet,1995,345:669-685.
3[3]Antman E M, Lau J, Kupelnick B, et al. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts: Treatments for myocardial infarction. JAMA,1992,327:248-254.
4[4]The Heart Outcome Prevention Evaluation (HOPE) Study Investigator. Effects of an angiotensin-converting enzyme inhibitor ramipril on cardiovascular events in high-risk patients. N Engl J Med,2000,342:145-153.
5[5]Freemantle N, Cleland J, Young P, Harrison, et al. b-blockade after myocardial infarction: Systematic review and meta regression analysis. BMJ,1999,318:1730-1737.
6[6]MRc/BHF Heart Protection Study Collaborative Group. Randomized trial of cholesterol-lowering with simvastatin in a wide range of patients at increased risk of vascular disease. Lancet ,2002,360:7-22.
